Thyroid Antibodies (TPO + TgAb)
Autoantibodies against thyroid peroxidase and thyroglobulin — markers of autoimmune thyroid disease.
Hashimoto's is the most common cause of hypothyroidism in developed countries, and antibodies appear years before TSH moves. Testing them explains 'why' and predicts trajectory. Far more common in women.
Check a Thyroid Antibodies (TPO + TgAb) result against this range →
What Thyroid Antibodies (TPO + TgAb) actually measures — the analyte, and the assay
Two analytes are reported under one heading. Thyroid peroxidase antibody is an IgG directed at the membrane-bound heme enzyme that iodinates tyrosine residues on thyroglobulin and couples them into hormone; thyroglobulin antibody targets the 660 kDa scaffold protein that reaction happens on. Both are polyclonal, both recognize conformational epitopes, and both are measured by competitive or two-site immunoassay against an antigen the manufacturer prepared.
That last clause is the reason a titer does not travel. One manufacturer coats its solid phase with purified human enzyme, another with a recombinant fragment, and each sets its own cut-off against its own reference cohort. The result is that a thyroid peroxidase antibody of 60 on one analyzer and 60 on another are not the same measurement in any meaningful sense — and unlike TSH, there is not even a shared international standard doing partial work in the background. The expert consensus written for the thyroglobulin side of this pair says the quantitative comparability problem out loud and tells laboratories not to switch methods mid-follow-up Giovanella 2023.
So the honest way to read this test is the way the immunology actually supports: positive or negative is a real result; the number beside it is a laboratory-specific index, not a disease score. Watching a titer fall from 340 to 210 across two different laboratories is watching two different rulers.
Thyroid Antibodies (TPO + TgAb): what changes the blood, and what only changes the reading
What changes the antibodies your immune system is making:
- Having autoimmune thyroid disease, which is what the test is for. In NHANES III, thyroid peroxidase antibodies were positive in 11.3% and thyroglobulin antibodies in 10.4% of a 17,353-person sample of the United States population — against clinical hypothyroidism in 0.3% and subclinical hypothyroidism in 4.3% Hollowell 2002. Roughly one person in nine carries the antibody and most of them do not have thyroid failure.
- Sex and age. Prevalence is several-fold higher in women and rises through midlife. It does not rise indefinitely: in older adults followed a median 7.8 years, thyroid peroxidase antibody concentrations fell by 0.6 U/L, about 11.2% Razvi 2024.
- Postpartum. The months after delivery are the single highest-risk window for a first presentation of autoimmune thyroiditis.
- Iodine intake. Populations moving from deficient to sufficient iodine see thyroid autoimmunity rise Li 2025.
- Immunotherapy. Checkpoint inhibitors precipitate thyroiditis in a substantial minority of those treated.
- Selenium — and here the honest answer is smaller than the internet's. Supplementation lowers measured titers in trials, but a 2021 assessment concluded there is insufficient evidence to support its clinical efficacy in chronic autoimmune thyroiditis Qiu 2021, and an overview of the systematic reviews reached a similarly guarded position Wang 2023. A falling titer is not the same event as a preserved thyroid.
What changes only the reading:
- Changing laboratory. The largest single source of an apparent change in titer, for the calibration reasons above Giovanella 2023.
- Where the manufacturer drew its cut-off. Prevalence in a population is a direct function of that decision; shift the threshold and you shift how many people 'have' autoimmunity without touching anyone's immune system Hollowell 2002.
- Heterophile antibodies and high rheumatoid factor, which interfere with these assays as they do with the hormone assays on the same panel Ghazal 2022.
- Recent intravenous immunoglobulin or a blood product, which transfers somebody else's antibodies into your sample.
Reference interval or decision threshold — which kind of number Thyroid Antibodies (TPO + TgAb) is
Neither a reference interval nor a decision threshold in the usual sense — it is a diagnostic cut-off, and it is a manufacturer's decision. The printed limit is the concentration above which that assay's own disease-free reference group was, by definition, unusual. It is calibrated to separate populations, not to grade an individual, and 'twice the cut-off' has no interpretation.
NHANES III shows what that means in practice. The survey defined a disease-free population of 16,533 people and then removed everyone with antibodies to build a reference population of 13,344 Hollowell 2002. The gap between those two numbers is antibody positivity, and it is the same gap that inflates a TSH reference interval built without antibody screening — which is why the two arguments on this site, the one about the TSH upper limit and the one about who should be tested for antibodies, are the same argument.
What the result is genuinely anchored to is a rate, not a state. Positive antibodies with a normal TSH predict a higher annual probability of progression to overt hypothyroidism; that is prognostic information, and it is the reason the test earns its place Razvi 2019. It is not a threshold at which anything should be prescribed.
How you would know your Thyroid Antibodies (TPO + TgAb) was wrong — and when to redraw
Once, in most people — and the reason is that the answer does not change what you do next. Antibody status is a classification, not a dial. Knowing you are positive changes the interpretation of every future TSH; knowing the titer has moved from 280 to 190 changes nothing, because no management decision anywhere is keyed to that number.
If it is repeated, three things must match: the same laboratory and the same method — the consensus for the thyroglobulin antibody explicitly warns against switching methods during follow-up Giovanella 2023 — and no recent immunoglobulin infusion.
What would have to change for a repeat to mean something. The marker that actually needs following is TSH, annually, because progression is defined by thyroid function and not by antibody concentration. A titer that halves while TSH climbs is not improvement; a titer that doubles while TSH stays at 1.8 mIU/L is not deterioration. Antibody concentrations also fall with age on their own Razvi 2024, so a decline over a decade is partly just time.
How you would know the value was wrong. A strongly positive antibody in someone with an entirely normal thyroid, no family history and no ultrasound changes is worth repeating once at a different laboratory before it is written into a record permanently — heterophile interference produces exactly that picture Ghazal 2022. Equally, a negative result does not close the question: seronegative Hashimoto's exists, and the confirmatory evidence there is ultrasound appearance plus the TSH trend, not a repeat antibody.
What Thyroid Antibodies (TPO + TgAb) cannot tell you
A positive antibody is not a treatment indication. This is the commonest wrong inference in the whole thyroid category. Treatment is decided by thyroid function: the largest randomized trial of levothyroxine in older adults with subclinical hypothyroidism found no improvement in hypothyroid symptoms or tiredness against placebo Stott 2017, and those participants were selected on TSH, not on antibodies. Nobody has randomized antibody-positive, euthyroid people to thyroid hormone and shown a benefit.
The titer does not measure disease activity or severity. It correlates weakly with how much thyroid is left and not at all with how somebody feels.
It cannot tell you which autoimmune thyroid disease you have. Thyroid peroxidase antibodies are common in Graves' disease as well as Hashimoto's. The antibody that separates them is the TSH-receptor antibody, which is a different test with a different purpose.
It cannot explain symptoms on its own. With a normal TSH, a normal free T4 and a positive antibody, the antibody is a statement about future risk. Attributing fatigue to it, and then treating the fatigue with thyroid hormone, is treating a prediction.
And a falling titer is not a cured thyroid. Selenium reliably moves the number and the evidence that it changes the disease is insufficient Qiu 2021 Wang 2023 — the clearest example on this site of a marker responding to an intervention that the outcome has not yet followed.
Sources read for these sections
- Hollowell JG, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994). Journal of Clinical Endocrinology and Metabolism 2002 · PMID 11836274
- Razvi SS, et al. Changes in Thyroid Function and Autoimmunity in Older Individuals: Longitudinal Analysis of the Whickham Cohort. Journal of Clinical Endocrinology and Metabolism 2024 · PMID 39673773
- Qiu Y, et al. Insufficient evidence to support the clinical efficacy of selenium supplementation for patients with chronic autoimmune thyroiditis. Endocrine 2021 · PMID 33774780
- Wang YS, et al. The Effects of Selenium Supplementation in the Treatment of Autoimmune Thyroiditis: An Overview of Systematic Reviews. Nutrients 2023 · PMID 37513612
- Stott DJ, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. New England Journal of Medicine 2017 · PMID 28402245
- Giovanella L, et al. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. European Journal of Endocrinology 2023 · PMID 37625447
- Razvi S, et al. Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction. Journal of Thyroid Research 2019 · PMID 31662841
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Biotin (B7). Biotin interferes with the streptavidin-biotin immunoassays most hormone tests run on. Depending on the assay design it pushes the result falsely HIGH or falsely LOW — there is no single direction to correct for. Hair, skin and nail products are the usual source, and doses in those are far above the RDA. Stop biotin 48–72 hours before the draw, and check every supplement label rather than just the one labeled biotin. - Read it with its partner
Test once if you have any thyroid symptoms or family history — it changes the interpretation of every future thyroid panel. Draw it alongside: TSH (Thyroid-Stimulating Hormone), Free T4 (Thyroxine), Free T3 (Triiodothyronine). - Work out which direction is yours
If it's high — Autoimmune thyroid disease. Predicts progression to overt hypothyroidism — worth monitoring TSH annually even if currently normal.
If it's low — Normal. - Fix it in this order
Nutrition. Selenium-rich foods (Brazil nuts). Screen for celiac disease — there's a well-documented association with autoimmune thyroid disease. Avoid excess iodine, which can drive antibody production higher.
Lifestyle. Manage stress, prioritize sleep, address gut health. Antibody levels often fluctuate with overall inflammatory load.
Supplements. Selenium has RCT evidence for reducing TPO antibody titers. Vitamin D (commonly low in autoimmunity), and myo-inositol combined with selenium shows promise in trials.
Hormones. Positive antibodies with normal TSH = monitor. Treatment begins when thyroid function actually declines — that's a physician's call.
Compounds. No peptide application, though systemic inflammation reduction may help overall.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
Annually if positive; TSH monitoring matters more than repeat antibody titers. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 Toulis KA et al., Thyroid 2010 — selenium supplementation and TPO antibodies meta-analysis.
This page can tell you what could have made your Thyroid Antibodies (TPO + TgAb) wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your Thyroid Antibodies (TPO + TgAb)
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Thyroid Antibodies (TPO + TgAb) is usually tested alongside
One marker is a data point. These panels add the markers that make Thyroid Antibodies (TPO + TgAb) interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 8 more markers — Anyone taking prescription lithium, and anyone taking low-dose lithium orotate as a longevity or mood supplement without ever having had a level checked.
includes this + 8 more markers — Joint pain, unexplained rashes, recurring low-grade fevers, profound fatigue, or a family history of autoimmune disease.
includes this + 8 more markers · built for women — Anywhere from 6 weeks to 18 months after giving birth, especially with exhaustion, hair shedding, mood changes, or a sense that you haven't bounced back.
What people use Thyroid Antibodies (TPO + TgAb) to decide
Nobody orders a test for its own sake. Thyroid Antibodies (TPO + TgAb) is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
Antibodies appear years before symptoms do. Thyroid antibodies in particular are worth knowing with a normal TSH, because they change how you'd approach iodine and selenium entirely.
TSH alone is not a thyroid panel. Normal TSH with low free T3 is impaired conversion, and it is the single most common thing missed in fatigue — you need the full set to see it.
Thyroid antibodies belong on this list even with a normal TSH — they independently raise miscarriage risk, and they are routinely left off fertility workups.
What moves your Thyroid Antibodies (TPO + TgAb)
3 supplements in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms Thyroid Antibodies (TPO + TgAb) helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Thyroid Antibodies (TPO + TgAb) might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Biotin interferes with the streptavidin-biotin immunoassays most hormone tests run on. Depending on the assay design it pushes the result falsely HIGH or falsely LOW — there is no single direction to correct for. Hair, skin and nail products are the usual source, and doses in those are far above the RDA.
Stop biotin 48–72 hours before the draw, and check every supplement label rather than just the one labeled biotin.
TPO and thyroglobulin antibody titres are not standardized between manufacturers. A value of 300 at one lab is not the same as 300 at another, so a 'rise' can be a change of lab.
Track antibodies at the same lab or not at all. Positive vs negative is the reliable read; the exact number is not.
Antibody titres shift substantially in the year after delivery as the immune system rebounds.
Interpret postpartum results against the delivery date.
What Thyroid Antibodies (TPO + TgAb) means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
Antibodies typically precede dysfunction by years. A normal TSH today does not mean nothing is happening — it means the gland is still compensating.
This is the window where it is worth acting. Monitor TSH and Free T4 every 6–12 months, ensure selenium is adequate, and address gut and vitamin D status. The Autoimmune Thyroid protocol covers the evidence and the noise.
What to test next
These put Thyroid Antibodies (TPO + TgAb) in context — each with its own full breakdown.
Frequently asked questions
TPO <9 IU/mL · TgAb <4 IU/mL (assay dependent). Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Negative/undetectable.
Autoimmune thyroid disease. Predicts progression to overt hypothyroidism — worth monitoring TSH annually even if currently normal.
Normal.
You can order Thyroid Antibodies (TPO + TgAb) directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework, and it splits by sex. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.